1 min read
Add as a preferred source on Google

Eli Lilly Posts $1.58 Billion in Third-Quarter Jardiance Sales, Up 64.5%

Jardiance sales increased 64.5% from the year-earlier quarter.

An amber medicine vial beside a rising row of pale tablets / TokenPost.ai
An amber medicine vial beside a rising row of pale tablets / TokenPost.ai

Eli Lilly’s Jardiance generated $1.58 billion in sales during the third quarter, a 64.5% increase from sales in the same quarter a year earlier.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…